Article
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma.
Clinical lung cancer - 1 Sept 2018
Taus Álvaro, Camacho Laura, Rocha Pedro, Hardy-Werbin Max, Pijuan Lara, Piquer Gabriel, López Eva, Dalmases Alba, Longarón Raquel, Clavé Sergi, Salido Marta, Albanell Joan, Bellosillo Beatriz, Arriola Edurne
Abstract excerpt
BACKGROUND: The assessment of epidermal growth factor receptor (EGFR) mutations is crucial for the management of patients with lung adenocarcinoma. Circulating tumor DNA (ctDNA)-based assessment offers advantages over tumor as a minimally invasive method able to capture tumor heterogeneity. PATIENTS AND METHODS: Consecutive patients diagnosed with EGFR-mutant lung adenocarcinoma in tumor biopsy were included in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.